Rebecca B. Perkins, MD, MSc

Associate Professor, Obstetrics & Gynecology

Rebecca Perkins
617.414.7308
85 E. Concord St

Biography

My area of research is cervical cancer prevention in underserved women. My current work focuses on HPV vaccination in females and males, as well as the impact of new screening guidelines on cervical dysplasia/cancer outcomes.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University

Websites

Education

  • Harvard Medical School, MD
  • Boston University School of Public Health, MSc
  • Stanford University, BA

Publications

  • Published on 1/12/2021

    Fenton ATHR, Orefice C, Eun TJ, Biancarelli D, Hanchate A, Drainoni ML, Perkins RB. Effect of provider recommendation style on the length of adolescent vaccine discussions. Vaccine. 2021 Feb 05; 39(6):1018-1023. PMID: 33446387.

    Read at: PubMed
  • Published on 1/1/2021

    Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, Feldman S. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. J Womens Health (Larchmt). 2021 Jan; 30(1):5-13. PMID: 33464997.

    Read at: PubMed
  • Published on 12/31/2020

    Fuzzell LN, Perkins R, Christy S, Lake PW, Vadaparampil ST. Hard to reach populations in cervical cancer screening in high income countries. Prev Med. 2020 Dec 31; 106400. PMID: 33388330.

    Read at: PubMed
  • Published on 12/28/2020

    Oliver K, Beskin K, Noonan L, Shah A, Perkins R, Humiston S. A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination. Pediatr Qual Saf. 2021 Jan-Feb; 6(1):e377. PMID: 33409429.

    Read at: PubMed
  • Published on 11/1/2020

    Eun TJ, Perkins RB. Screening for Cervical Cancer. Med Clin North Am. 2020 Nov; 104(6):1063-1078. PMID: 33099451.

    Read at: PubMed
  • Published on 10/25/2020

    Bronico JVR, Matthews BJ, Perkins RB, Lee EM, Morgan JR, Nitschmann CC, Paasche-Orlow MK. Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. J Minim Invasive Gynecol. 2020 Oct 25. PMID: 33115685.

    Read at: PubMed
  • Published on 10/6/2020

    Saraiya M, Cheung LC, Soman A, Mix J, Kenney K, Chen X, Perkins RB, Schiffman M, Wentzensen N, Miller J. Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017. Am J Obstet Gynecol. 2020 Oct 06. PMID: 33035473.

    Read at: PubMed
  • Published on 10/1/2020

    Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020 Oct; 24(4):426. PMID: 32732648.

    Read at: PubMed
  • Published on 9/25/2020

    Sawaya GF, Lamar R, Perkins RB. Managing Minimally Abnormal Cervical Cancer Screening Test Results. JAMA. 2020 Sep 25. PMID: 32975557.

    Read at: PubMed
  • Published on 9/12/2020

    Gilkey MB, Bednarczyk RA, Gerend MA, Kornides ML, Perkins RB, Saslow D, Sienko J, Zimet GD, Brewer NT. Getting Human Papillomavirus Vaccination Back on Track: Protecting Our National Investment in Human Papillomavirus Vaccination in the COVID-19 Era. J Adolesc Health. 2020 11; 67(5):633-634. PMID: 32933839.

    Read at: PubMed

View 93 more publications: View full profile at BUMC

View all profiles